|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001899,
umls-concept:C0009429,
umls-concept:C0026336,
umls-concept:C0035668,
umls-concept:C0220847,
umls-concept:C0556895,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-2-5
|
|
pubmed:abstractText |
Standard models simulate the dynamics of hepatitis C virus (HCV) infection using HCV RNA kinetics and show a correlation between the clearance of infected hepatocytes and response to interferon. However, they are unable to predict whether the response will be maintained. The aim of our work was to identify criteria by which sustained responses may be predicted and defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
519-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14760885-Alanine Transaminase,
pubmed-meshheading:14760885-Antiviral Agents,
pubmed-meshheading:14760885-Drug Therapy, Combination,
pubmed-meshheading:14760885-Female,
pubmed-meshheading:14760885-Hepatitis C,
pubmed-meshheading:14760885-Humans,
pubmed-meshheading:14760885-Interferons,
pubmed-meshheading:14760885-Male,
pubmed-meshheading:14760885-Models, Theoretical,
pubmed-meshheading:14760885-RNA, Viral,
pubmed-meshheading:14760885-Ribavirin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.
|
|
pubmed:affiliation |
UO Gastroenterologia ed Epatologia, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
